Similar companies
Actinium Pharmaceuticals Monthly Web Traffic
Actinium Pharmaceuticals’s website receives an estimated 7,000 monthly visits, roughly flat (+0.0%) over the past three months.
At 7,000 monthly visits, Actinium Pharmaceuticals trails industry peers like Amgen (665,000) and Gilead Sciences (511,000).
How Web Traffic Impacts ATNM’s AI Score
Web traffic is a real-time read on consumer demand and brand engagement: for consumer-facing companies, a sustained change in website visits can precede changes in reported revenue. AltIndex feeds Actinium Pharmaceuticals’s monthly visit estimates into the ATNM AI Score as one of 25+ alternative data signals, where traffic momentum is weighed against hiring, sentiment, and fundamentals.
For other growth metrics, see Actinium Pharmaceuticals app downloads, Google Trends, Instagram followers, and LinkedIn headcount.
Month over Month
| Sep 2026 | 7,000 | |
| Aug 2026 | 4,000 | |
| Jul 2026 | 5,000 | |
| Jun 2026 | 7,000 | |
| May 2026 | 2,000 | |
| Apr 2026 | 4,000 |
Actinium Pharmaceuticals Web Traffic: Frequently Asked Questions
Actinium Pharmaceuticals's website receives approximately 7,000 monthly visits, based on AltIndex's estimate aggregated from the top web traffic data providers. This figure includes desktop and mobile visitors to the company's primary domain.
Actinium Pharmaceuticals's web traffic has been roughly flat (+0.0%) over the past three months.
Web traffic is a real-time indicator of consumer demand and brand engagement. For consumer-facing companies, declining website visits can precede revenue slowdowns. AltIndex tracks web traffic as one of 25+ signals in its AI Score model.
No single data point predicts a stock price on its own, but website traffic is a leading indicator: a sustained shift in Actinium Pharmaceuticals's monthly visitors can show up before it reaches reported revenue. That is why AltIndex combines ATNM's web traffic trend with hiring, sentiment, app downloads, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Actinium Pharmaceuticals underperforms its industry peers when it comes to Webpage traffic, ranking dead last.
Sign up and get more insights on Actinium Pharmaceuticals and its Webpage performance.
See Actinium Pharmaceuticals’s complete webpage traffic history
Sign up to unlock 1-year and all-time charts for ATNM, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
